Akif Ayaz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Akif Ayaz has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Burcu Ozturk Hismi
School of Medicine, Marmara University
1 shared publication - Dilşad Türkdoğan
Department of Pediatric Neurology, Marmara University Faculty of Medicine, Pendik Training and Research Hospital, Istanbul, Türkiye
1 shared publication - Gulten Ozturk
Department of Pediatric Neurology, Marmara University Faculty of Medicine, Pendik Training and Research Hospital, Istanbul, Türkiye
1 shared publication - Kürşad Aydın
Department of Pediatric Neurology, Faculty of Medicine, Medipol University, İstanbul, Turkey
1 shared publication - Olcay Ünver
Environmental and Resource Management Program, Fulton Schools of Engineering, Arizona State University, Tempe, AZ 85287-9309, USA
1 shared publication - İsmail Hakkı Akbeyaz
Department of Pediatric Neurology, Pendik Research and Training Hospital, Marmara University, İstanbul, Türkiye
1 shared publication
Latest Publications
- 17 December 2024
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 38 (2) , 196-200
Unclear symptoms, early diagnosis and perfect outcome: a case diagnosed as sepiapterin reductase deficiency hidden behind vitamin B12 deficiency
Objectives: Sepiapterin reductase deficiency (SRD) is a rare dopa-sensitive neurotransmitter disorder caused by autosomal recessive mutations in the sepiapterin reductase gene. The triad of paroxysmal stiffening, oculogyric crises, and hypotonia are highly suggestive in some patients. However, in other patients, the clinical picture may be nonspecific and remain under-recognized and misdiagnosed as cerebral palsy. Case presentation: We present a nine-month-old boy who initially presented with hypotonia and developmental delay, diagnosed as vitamin B12 deficiency. Upon he did not respond to vitamin replacement treatment, he was diagnosed with SRD by whole-exome sequencing (WES). The boy improved dramatically under treatment with L-dopa, 5-hydroxytryptophan and BH4. Conclusions: We aim to emphasize that SRD can present with nonspecific symptoms, leading to a diagnostic delay for this rare but treatable disease. Moreover, our case is the first to demonstrate the clinical benefit of BH4 add-on treatment. Early intervention is crucial for good outcome and neurodevelopment.
- 17 December 2024
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 38 (2) , 196-200
Unclear symptoms, early diagnosis and perfect outcome: a case diagnosed as sepiapterin reductase deficiency hidden behind vitamin B12 deficiency
Objectives: Sepiapterin reductase deficiency (SRD) is a rare dopa-sensitive neurotransmitter disorder caused by autosomal recessive mutations in the sepiapterin reductase gene. The triad of paroxysmal stiffening, oculogyric crises, and hypotonia are highly suggestive in some patients. However, in other patients, the clinical picture may be nonspecific and remain under-recognized and misdiagnosed as cerebral palsy. Case presentation: We present a nine-month-old boy who initially presented with hypotonia and developmental delay, diagnosed as vitamin B12 deficiency. Upon he did not respond to vitamin replacement treatment, he was diagnosed with SRD by whole-exome sequencing (WES). The boy improved dramatically under treatment with L-dopa, 5-hydroxytryptophan and BH4. Conclusions: We aim to emphasize that SRD can present with nonspecific symptoms, leading to a diagnostic delay for this rare but treatable disease. Moreover, our case is the first to demonstrate the clinical benefit of BH4 add-on treatment. Early intervention is crucial for good outcome and neurodevelopment.